menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Bradley E. Chipps, MD, FAAP, FACAAI, FAAAAI, FCCP
Bradley E. Chipps, MD, FAAP, FACAAI, FAAAAI, FCCP
  • Past-President
  • American College of Allergy, Asthma & Immunology
  • Medical Director
  • Capital Allergy & Respiratory Disease Center

Dr. Bradley E. Chipps received his MD from the University of Texas Medical Branch in Galveston in 1972. He was a pediatric resident for two years before serving in the Air Force at Ellsworth AFB in South Dakota for two years as a general pediatrician. He then completed a combined allergy and pulmonary fellowship at Johns Hopkins and spent one year on the faculty in the pediatric respiratory sciences division.

He has been in private practice in Sacramento since 1979. Dr. Chipps is the medical director of respiratory therapy at the Cystic Fibrosis Center at Sutter Medical Center in Sacramento, California. He is also the associate medical director of the Sutter Community Hospitals Sleep Laboratory which he established in 1984. He is board certified in pediatric pulmonology and allergy and clinical immunology. Dr. Chipps is a member of American Academy of Pediatrics, American College of Chest Physicians, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, American Thoracic Society. He is currently serving on the board of regents of the ACAAI and the allergy immunology executive committee for the American Academy of Pediatrics. He has served on the program committee for the American Thoracic Society and the AAAAI.

Dr. Chipps' special interests include clinical research, scientific lecturing and resident physician teaching, which has been an increasing part of his practice for the last ten years  He continues to actively contribute to the literature on a regular basis.

Dr. Chipps' current research projects include: developing protocols for the assessment and treatment of acute, severe asthma and working on the advisory committee of Genentech's Tenor study. He is investigating the factors associated with continued symptomatology and airflow limitation in severe persistent asthma.

Schedule20 Apr 2024